Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-304P is a human genomic locus representing a pseudogene of the U6 small nuclear RNA gene family. U6 snRNA is a core member of the spliceosome, the molecular machinery that removes introns from pre-mRNA in the nucleus of eukaryotic cells[1][3]. Pseudogenes such as RNU6-304P arise from ancestral gene duplication or retrotransposition events and typically accumulate mutations that render them non-functional[5]. While some pseudogenes can be transcribed and may have regulatory functions—for example, acting as competing endogenous RNAs (ceRNAs) or "miRNA sponges"—there is no evidence that RNU6-304P possesses a defined function, nor is it established as a therapeutic target or biomarker[4]. It should not be confused with the functional U6 snRNA, which is essential for spliceosomal catalysis[1][3]. If you require information on the functional U6 small nuclear RNA, it is important to note the difference between the functional gene and its numerous pseudogenes, of which RNU6-304P is one example.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 304, pseudogene (RNU6-304P).